AQA
BMY icon

Alpha Quant Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Alpha Quant Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.23M Sell
25,809
-2,262
-8% -$113K 1.23% 23
2018
Q4 		$1.46M Buy
+28,071
New +$1.51M 1.51% 12

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Alpha Quant Advisors's BMY Position: Q1 2019 in Review

Alpha Quant Advisors reduced its Bristol-Myers Squibb (BMY) stake by 8.1% in Q1 2019, selling an estimated $113K and leaving 25,809 shares worth $1.23M. The position accounts for 1.23% of the portfolio, ranked #23.

Alpha Quant Advisors first reported a position in BMY in Q4 2018 and has held it in 2 quarters since. The position peaked at $1.46M in Q4 2018. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Alpha Quant Advisors held 25,809 shares of Bristol-Myers Squibb worth $1.23M as of Q1 2019.
  • Alpha Quant Advisors sold 2,262 Bristol-Myers Squibb shares in Q1 2019, an estimated $113K.
  • Bristol-Myers Squibb made up 1.23% of Alpha Quant Advisors's portfolio in Q1 2019, its #23 holding.
  • Alpha Quant Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 2 quarters since.
  • Alpha Quant Advisors's Bristol-Myers Squibb position peaked at $1.46M in Q4 2018.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.